Evidence map›Paper›PMID 40255121›Full record

ReviewProteomics2025

Glycoproteomics and Its Role in Understanding Bacterial O-Linked Glycosylation.

Kristian I Karlic, Hamza Tahir, Nichollas E Scott

Abstract readReview
In one paragraph

Review in Proteomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kristian I KarlicDepartment of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Hamza TahirDepartment of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Nichollas E ScottDepartment of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0003-2556-8316

Funding

Australian Research Council (ARC) Future Fellowship FT200100270National Health and Medical Research Council 2018980
6 · The paper itself

Abstract

Protein glycosylation is now recognized as a ubiquitous process observed in all domains of life. Within bacterial species, carbohydrates can be attached to multiple residues with glycosylation of serine, threonine, or tyrosine residues via their hydroxyl side chains referred to as O-linked glycosylation. To date, multiple bacterial enzymes have been identified that mediate O-linked glycosylation targeting either surface or periplasmic bacterial proteins, and in the case of toxin/effectors, host proteins. Within this review, we discuss the current understanding of common bacterial O-linked glycosylation systems and the glycoproteomic approaches which have been used to characterize these events. Focusing on O-oligosaccharyltransferases (O-OTases), flagellin-specific glycosylation systems, and glycosyltransferase toxin/effectors, we discuss the characteristics of known glycosylation systems. For the general O-linked systems mediated by the PglL oligosaccharyltransferases, we outline the key considerations when assessing glycosylation events across the Burkholderia, Neisseria, and Acinetobacter genera. In addition, we highlight the technologies and advancements in glycoproteomic techniques, as well as the bioinformatic tools that now facilitate high throughput studies of O-linked glycosylation within bacterial species. Combined, this review outlines our current understanding of O-linked glycosylation within well characterized Gram-negative genera and the current technologies available for exploring bacterial O-glycoproteomes.

Indexed as

BacteriaBacterial ProteinsGlycoproteinsProteomicsGlycosylationGlycosyltransferasesHexosyltransferasesBacterial ProteinsGlycoproteinsGlycosyltransferasesHexosyltransferasesbacteriaglycoproteomicsO‐glycosylationO‐OTasePglLpost‐translational modifications

Identifiers

PMID40255121
PMCPMC12645811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.